AML CD34+ blast cellsexpressed significantly reduced RIP3 mRNA compared with CD34+ cellsfrom healthy donors (Figure 1a), whereas theexpression of RIP1 did not differ significantly (Figure1b). The gene discussed is RIPK1; the disease is acute myeloid leukemia.